Stuart Gunzburg has an extensive background in medical research having completed his PhD at The University of Western Australia and subsequently holding positions at Cornell University in New York and the Hebrew University in Jerusalem.
Dr Gunzburg completed his MBA at The University of Western Australia majoring in finance. He has worked in the capital markets as a health and biotechnology analyst and investment advisor. He has been involved in a number of start up ventures covering a diverse range of applications including anti-cancer drug development, renewable fuel production, waste management system developments and technology applications in the explosives industry.